StockData
Gilead Sciences, Inc. logo

Gilead Sciences, Inc.

GILDNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026Score 11/30105% above fair value
$170.33−0.35 (-0.21%)

Close on Nov 2, 2026Market cap $211.20BP/E –Yield 1.86%

Gilead Sciences RSU rollforward by Year

RSU rollforward — Nonvested shares at period-end (M shares)

Gilead Sciences RSU rollforward: 18 in FY2025, down 18.3% from a year earlier.

Latest, FY2025
18
Period ended Dec 31, 2025
Change on a year earlier
-18.3%
22 in FY2024
History
10 years
Since FY2014
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-24) ↗

Reported in Form 10-K Note 13 Stock-Based Compensation.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedRSU rollforward — Nonvested shares at period-end (M shares)Year on yearSource
FY2025Dec 31, 202518-18.3%Form 10-K (filed 2026-02-24) ↗
FY2024Dec 31, 202422-4.0%Form 10-K (filed 2026-02-24) ↗
FY2023Dec 31, 202323-3.8%Form 10-K (filed 2025-02-28) ↗
FY2022Dec 31, 202224+12.9%Form 10-K (filed 2024-02-23) ↗
FY2021Dec 31, 202121+7.2%Form 10-K (filed 2023-02-22) ↗
FY2020Dec 31, 202020+13.4%Form 10-K (filed 2022-02-23) ↗
FY2019Dec 31, 201917+15.5%Form 10-K (filed 2021-02-25) ↗
FY2018Dec 31, 201815-0.8%Form 10-K (filed 2019-02-26) ↗
FY2017Dec 31, 201715–Form 10-K (filed 2019-02-26) ↗
FY2014Dec 31, 201414–Form 10-K (filed 2015-02-25) ↗

Breakdown

What makes up RSU rollforward

Cite this data

StockData. (2026). Gilead Sciences RSU rollforward, annual FY2014–FY2025 [Data set]. Compiled from Gilead Sciences SEC filings and investor materials. https://stockdatahq.com/stocks/gild/kpis/rsu-nonvested-sh

See every metric in the Gilead Sciences KPI table. Data updated Oct 29, 2026.